Phase I Trial of Lenalidomide in Pediatric Patients With Recurrent, Refractory, or Progressive Primary CNS Tumors: Pediatric Brain Tumor Consortium Study PBTC-018

PURPOSE: A phase I trial of lenalidomide was performed in children with recurrent, refractory, or progressive primary CNS tumors to estimate the maximum-tolerated dose (MTD) and to describe the toxicity profile and pharmacokinetics. PATIENTS AND METHODS: Lenalidomide was administered by mouth daily...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Warren, Katherine E., Goldman, Stewart, Pollack, Ian F., Fangusaro, Jason, Schaiquevich, Paula, Stewart, Clinton F., Wallace, Dana, Blaney, Susan M., Packer, Roger, MacDonald, Tobey, Jakacki, Regina, Boyett, James M., Kun, Larry E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3056466/
https://ncbi.nlm.nih.gov/pubmed/21149652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.3601
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados